What is the Average Survival Rate for Multiple Myeloma?
The lifetime risk for multiple myeloma is about 1 in 143.
The 5-year survival rate tells you what percent of people with the same type and stage of cancer live at least 5 years after they were diagnosed (percent means how many out of 100). These rates can’t tell you how long you will live, but they may help give you a better understanding about how likely it is that your treatment will be successful.
As of 2018:
- For people with multiple myeloma, the 5-year survival rate is about 50%.
- For the 5% of people who are diagnosed at an early stage, the 5-year survival rate is 71%.
- If the cancer has spread to a distant part of the body, the 5-year survival rate is 48%.
The outlook for people with multiple myeloma varies by the stage (extent) of the cancer. In general, the survival rates are higher for people with earlier stage cancers (in this case, 23% higher). However, the outlook for each person is specific to his or her circumstances.
Remember that all survival rates are estimates. Survival rates have steadily increased over the last decade, so the 5-year survival rate may underestimate the impact of recent progress made in the treatment of Multiple Myeloma. It is important to keep in mind the many factors that can affect a person’s outlook, such as their age and overall health, genetics, and how well the cancer responds to treatment. Your doctor can tell you how these numbers apply to you.
As Myeloma Patients, it is vital we continue making positive lifestyle decisions to prioritize health, personal care and wellbeing, and recognize the impact of even the smallest choices during our treatment. We have provided the HealthTree tool to monitor and stay informed on your best possible treatment options and provided the Myeloma Coaching Program for your convenience. Find out what treatments have the highest efficacy ratings for you today and talk about it with your doctor. Every step counts!
**Statistics on the survival rates for people with multiple myeloma are an estimate. The estimate comes from annual data based on the number of people with this cancer in the United States. Also, experts measure the survival statistics every 5 years. So the estimate may not show the results of better diagnosis or treatment available for less than 5 years. People should talk with their doctor if they have any questions about this information.
Statistics adapted from the American Cancer Society’s (ACS) publication, Cancer Facts and Figures 2018, the ACS website, and the National Cancer Institute Surveillance Epidemiology and End Results (SEER) database.